HEALTHJun 7 · 13:53 UTCCBS NEWS

The promises and pitfalls of GLP-1 drugs

GLP-1 drugs, approved 20 years ago for diabetes treatment, have helped over 30 million U.S. patients reduce weight but are associated with troubling side effects.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GLP-1 drugstopicdiabetestopicweight losstopicside effectstopicUnited Statesplace

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 7 · 13:28 UTC
The promises and pitfalls of GLP-1 drugs
HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHMay 21 · 13:02 UTC
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
HEALTHMay 7 · 10:11 UTC
Scientists discover why Ozempic works better for some people
HEALTHApr 16 · 03:50 UTC
This cheap drug could help people with type 1 diabetes use less insulin
HEALTHJun 3 · 13:17 UTC
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more